CD4 and neoplasm: We also found that infiltrating CD4 and CD8 lymphocytes showed changes in markers of T cell activation and exhaustion upon repeated mCelyvir administration [32], suggesting continued activity of the tumor infiltrating T lymphocytes (TILs).